Our transdisciplinary approach not only establishes FZD2 as a tissue-specific pan-cancer biomarker with dual utilities (prognostic and therapeutic) but also demonstrates how integrated multi-omics strategies can uncover actionable targets for precision oncology. Here, FZD2 is linked to cancer.